Thomas Ramdahl

Dr Ramdahl is a pharmaceutical executive with more than 20 years of clinical and development experience. In 2001, he became President and the first CEO of Algeta ASA. Dr Ramdahl has authored more than 40 publications and is a co-inventor of several patents. Dr Ramdahl currently serves as a non-executive direct of Precirix (Belgium)

Holding

Company	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
CU6	21/03/24	520,000	N/A	200,000	N/A

Transactions

Company	Date	Type	Amount	Price	Value	Notes
CU6	20/11/24	Issued	17,080	$5.446	$93,018	Issue of options
CU6	01/10/24	Buy	200,000	$0.825	$165,000	Exercise of options
CU6	01/10/24	Exercise	200,000	$0.825	$165,000	Exercise of options
CU6	21/03/24	Buy	400,000	$0.605	$242,000	Exercise of options
CU6	21/03/24	Exercise	400,000	$0.605	$242,000	Exercise of options

Any feedback about this profile? Contact Us

My Watchlists

Fetching your watchlist...